317 related articles for article (PubMed ID: 37966552)
41. Immunosuppressive Traits of the Hybrid Epithelial/Mesenchymal Phenotype.
Sahoo S; Nayak SP; Hari K; Purkait P; Mandal S; Kishore A; Levine H; Jolly MK
Front Immunol; 2021; 12():797261. PubMed ID: 34975907
[TBL] [Abstract][Full Text] [Related]
42. Tumor plasticity interferes with anti-tumor immunity.
Chouaib S; Janji B; Tittarelli A; Eggermont A; Thiery JP
Crit Rev Immunol; 2014; 34(2):91-102. PubMed ID: 24940910
[TBL] [Abstract][Full Text] [Related]
43. Epithelial-to-Mesenchymal Transition in Metastasis: Focus on Laryngeal Carcinoma.
Goulioumis A; Gyftopoulos K
Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140250
[TBL] [Abstract][Full Text] [Related]
44. The Antitumor Cytotoxic Response: If the Killer Cells Play the Music, the Microenvironmental Hypoxia Plays the Tune.
Chouaib S
Crit Rev Immunol; 2020; 40(2):157-166. PubMed ID: 32749093
[TBL] [Abstract][Full Text] [Related]
45. Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia.
Marie-Egyptienne DT; Lohse I; Hill RP
Cancer Lett; 2013 Nov; 341(1):63-72. PubMed ID: 23200673
[TBL] [Abstract][Full Text] [Related]
46. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
47. Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma.
Zhang Y; Zhang X; Huang X; Tang X; Zhang M; Li Z; Hu X; Zhang M; Wang X; Yan Y
Stem Cell Res Ther; 2023 Feb; 14(1):15. PubMed ID: 36721217
[TBL] [Abstract][Full Text] [Related]
48. Targeting EMT in cancer: opportunities for pharmacological intervention.
Davis FM; Stewart TA; Thompson EW; Monteith GR
Trends Pharmacol Sci; 2014 Sep; 35(9):479-88. PubMed ID: 25042456
[TBL] [Abstract][Full Text] [Related]
49. Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review.
Wang S; Huang S; Sun YL
Biomed Res Int; 2017; 2017():2646148. PubMed ID: 29379795
[TBL] [Abstract][Full Text] [Related]
50. EMT- and MET-related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities.
Kahlert UD; Joseph JV; Kruyt FAE
Mol Oncol; 2017 Jul; 11(7):860-877. PubMed ID: 28556516
[TBL] [Abstract][Full Text] [Related]
51. The role of the epithelial-to-mesenchymal transition (EMT) in diseases of the salivary glands.
Sisto M; Lisi S; Ribatti D
Histochem Cell Biol; 2018 Aug; 150(2):133-147. PubMed ID: 29789993
[TBL] [Abstract][Full Text] [Related]
52. SNAIL1: Linking Tumor Metastasis to Immune Evasion.
Tang X; Sui X; Weng L; Liu Y
Front Immunol; 2021; 12():724200. PubMed ID: 34917071
[TBL] [Abstract][Full Text] [Related]
53. Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.
Leung D; Price ZK; Lokman NA; Wang W; Goonetilleke L; Kadife E; Oehler MK; Ricciardelli C; Kannourakis G; Ahmed N
J Transl Med; 2022 Dec; 20(1):556. PubMed ID: 36463238
[TBL] [Abstract][Full Text] [Related]
54. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
Li H; Xu F; Li S; Zhong A; Meng X; Lai M
Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
[TBL] [Abstract][Full Text] [Related]
55. The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN Circuitry.
Bonavida B; Baritaki S
Crit Rev Oncog; 2011; 16(3-4):211-26. PubMed ID: 22248055
[TBL] [Abstract][Full Text] [Related]
56. The evolving concept of cancer stem-like cells in thyroid cancer and other solid tumors.
Hardin H; Zhang R; Helein H; Buehler D; Guo Z; Lloyd RV
Lab Invest; 2017 Oct; 97(10):1142-1151. PubMed ID: 28394318
[TBL] [Abstract][Full Text] [Related]
57. PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung.
Kim S; Koh J; Kim MY; Kwon D; Go H; Kim YA; Jeon YK; Chung DH
Hum Pathol; 2016 Dec; 58():7-14. PubMed ID: 27473266
[TBL] [Abstract][Full Text] [Related]
58. The role of tumor microenvironment on cancer stem cell fate in solid tumors.
Razi S; Haghparast A; Chodari Khameneh S; Ebrahimi Sadrabadi A; Aziziyan F; Bakhtiyari M; Nabi-Afjadi M; Tarhriz V; Jalili A; Zalpoor H
Cell Commun Signal; 2023 Jun; 21(1):143. PubMed ID: 37328876
[TBL] [Abstract][Full Text] [Related]
59. Immune evasion by cancer stem cells.
Tsuchiya H; Shiota G
Regen Ther; 2021 Jun; 17():20-33. PubMed ID: 33778133
[TBL] [Abstract][Full Text] [Related]
60. Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis.
Lu W; Kang Y
Dev Cell; 2019 May; 49(3):361-374. PubMed ID: 31063755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
